EnVVeno Medical Corporation
NVNO
Rangering i aksjer
#40242
enVVeno Medical Corporation, based in Irvine, California, is a medical device... enVVeno Medical Corporation, based in Irvine, California, is a medical device firm founded in 1999 that is currently in its clinical development phase. The company's primary objective is to pioneer advanced bioprosthetic, tissue-engineered solutions intended to significantly elevate the existing standards of care for patients suffering from venous conditions. Their flagship product is the VenoValve, a specialized replacement venous valve developed for the management of chronic venous insufficiency. This device requires an open surgical procedure for implantation, which involves making a 5-to-6-inch incision in the patient's upper thigh to facilitate placement into the femoral vein. In addition to the VenoValve, enVVeno Medical is actively developing the enVVe system. This innovative system represents a non-surgical, transcatheter approach to venous valve replacement, comprising the enVVe valve itself, a dedicated delivery mechanism, and various supplementary accessories. The company previously operated under the name Hancock Jaffe Laboratories, Inc., before officially rebranding to enVVeno Medical Corporation in October 2021.
Aksjekurs
$10.71
Sist synkronisert: 2026-07-31
Markedsverdi
$176.75K
Endring (1 dag)
0.79%
Endring (1 år)
169,900.00%
Land
US
Handel EnVVeno Medical Corporation (NVNO)
Kategori
Healthcare
Antall utestående aksjer for EnVVeno Medical Corporation (NVNO)
Antall utestående aksjer per October 2026: 0
Ifølge EnVVeno Medical Corporation sine siste økonomiske rapporter og aksjekurs er antall utestående aksjer nå 0. Ved slutten av October 2026 hadde selskapet 0 utestående aksjer. Antallet utestående aksjer påvirkes vanligvis av aksjesplitt og tilbakekjøp.
Historikk over utestående aksjer for EnVVeno Medical Corporation (NVNO) fra 2026 til 2026
Utestående aksjer ved utgangen av hvert år
| År | Utestående aksjer | Endre |
|---|---|---|
| Ikke nok data for de angitte datoene. | ||
Utestående aksjer for lignende selskaper eller konkurrenter
| Selskap | Utestående aksjer | Forskjell | Land |
|---|---|---|---|
| 1.74B | - |
US
|
|
| 1.28B | - |
IE
|
|
| 383.50M | - |
US
|
|
| 1.48B | - |
US
|
|
| - | - |
DE
|
